Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
The new Biolys provides higher concentration of L-lysine
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
The company moves a step closer towards achieving its goal of emerging as the top oncology medicine supplier from India in the ASEAN region
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Subscribe To Our Newsletter & Stay Updated
